Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIP: HSV-2 Suppression in Pregnancy
NCT00530777Phase 2Completed
- Sponsor
- University of Washington
- Start
- Apr 2008
- Primary completion
- Aug 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of valaciclovir in herpes simplex virus type 2 infection, sponsored by University of Washington. Started Apr 2008; status: completed.
02
Drugs
valaciclovir
03
Conditions
herpes simplex virus type 2 infection
Beyond the preview
Go deeper on NCT00530777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530777.